Literature DB >> 6307567

Alterations of peripheral blood lymphocyte cyclic AMP and cyclic GMP in untreated patients with hodgkin's disease.

A Aleksijevic, J M Lang, C Giron, J C Stoclet, S Mayer, F Oberling.   

Abstract

Cyclic AMP and cyclic GMP are important regulatory agents of lymphocyte functions. Depressed T-lymphocyte functions are frequently associated with Hodgkin's disease and suppressor monocytes have been implicated in the pathogenesis of this defect. In the present study cAMP and cGMP resting levels were measured in lymphocytes from 18 untreated patients with Hodgkin's disease using a sensitive radioimmunoassay. A significant decrease of cAMP (P less than 0.001) and, to a lesser degree, of cGMP (P less than 0.01) was found in monocyte-depleted lymphocyte suspensions from the patients compared to controls. Studies of patient and control lymphocyte subpopulations showed in patients a clear deficit of cAMP in T-depleted lymphocytes, rather than in T cells, with a low cAMP/cGMP molar ratio in both subpopulations. From this data it is clear that factors other than prostaglandin-mediated suppression of monocyte origin are involved in the pathogenesis of the T-lymphocyte depression associated with Hodgkin's disease.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6307567     DOI: 10.1016/0090-1229(83)90124-1

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  5 in total

1.  Normal peripheral-blood lymphocyte cAMP and cGMP resting levels in untreated patients with mycosis fungoides.

Authors:  A Aleksijevic; P Caussade; J M Lang; J C Stoclet; E Grosshans; S Mayer
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

2.  DHA induces apoptosis of human malignant breast cancer tissues by the TLR-4/PPAR-α pathways.

Authors:  Lijing Geng; Wei Zhou; Bing Liu; Xinyun Wang; Bo Chen
Journal:  Oncol Lett       Date:  2017-12-28       Impact factor: 2.967

Review 3.  From purines to purinergic signalling: molecular functions and human diseases.

Authors:  Zhao Huang; Na Xie; Peter Illes; Francesco Di Virgilio; Henning Ulrich; Alexey Semyanov; Alexei Verkhratsky; Beata Sperlagh; Shu-Guang Yu; Canhua Huang; Yong Tang
Journal:  Signal Transduct Target Ther       Date:  2021-04-28

4.  The effect of cyclic nucleotide analog drugs on the mediators release from basophils.

Authors:  Nahid Eskandari; Reza Bastan; Seyyed Hamid Zarkesh Esfahani; Peter T Peachell
Journal:  Adv Biomed Res       Date:  2015-06-04

5.  The role of cyclic nucleotide signaling pathways in cancer: targets for prevention and treatment.

Authors:  Alexandra M Fajardo; Gary A Piazza; Heather N Tinsley
Journal:  Cancers (Basel)       Date:  2014-02-26       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.